Kirk Look - Net Worth and Insider Trading
Kirk Look Net Worth
The estimated net worth of Kirk Look is at least $16,931 dollars as of 2024-11-13. Kirk Look is the Senior Officer of Oncolytics Biotech Inc and owns about 10,923 shares of Oncolytics Biotech Inc (TSX:ONC) stock worth over $16,931. Details can be seen in Kirk Look's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kirk Look has not made any transactions after 2019-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kirk Look
Kirk Look Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kirk Look owns 1 companies in total, including Oncolytics Biotech Inc (TSX:ONC) .
Click here to see the complete history of Kirk Look’s form 4 insider trades.
Insider Ownership Summary of Kirk Look
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:ONC | Oncolytics Biotech Inc | 2019-06-18 | Senior Officer |
Kirk Look Latest Holdings Summary
Kirk Look currently owns a total of 1 stock. Kirk Look owns 10,923 shares of Oncolytics Biotech Inc (TSX:ONC) as of June 18, 2019, with a value of $16,931.
Latest Holdings of Kirk Look
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:ONC | Oncolytics Biotech Inc | 2019-06-18 | 10,923 | 1.55 | 16,931 |
Holding Weightings of Kirk Look
Kirk Look Form 4 Trading Tracker
According to the SEC Form 4 filings, Kirk Look has made a total of 0 transactions in Oncolytics Biotech Inc (TSX:ONC) over the past 5 years. The most-recent trade in Oncolytics Biotech Inc is the acquisition of 1,500 shares on June 18, 2019, which cost Kirk Look around $3,371.
Insider Trading History of Kirk Look
- 1
Kirk Look Trading Performance
GuruFocus tracks the stock performance after each of Kirk Look's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kirk Look is -24.62%. GuruFocus also compares Kirk Look's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kirk Look within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kirk Look's insider trading performs compared to the benchmark.
Performance of Kirk Look
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.97 | | | | | |
| Relative Return to S&P 500(%) | -0.62 | | | | | |
Kirk Look Ownership Network
Ownership Network List of Kirk Look
Ownership Network Relation of Kirk Look
Kirk Look Owned Company Details
What does Oncolytics Biotech Inc do?
Who are the key executives at Oncolytics Biotech Inc?
Kirk Look is the Senior Officer of Oncolytics Biotech Inc. Other key executives at Oncolytics Biotech Inc include and Director & Senior Officer Matthew Coffey .
Oncolytics Biotech Inc (TSX:ONC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncolytics Biotech Inc (TSX:ONC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncolytics Biotech Inc (TSX:ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncolytics Biotech Inc (TSX:ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncolytics Biotech Inc Insider Transactions
Kirk Look Mailing Address
Above is the net worth, insider trading, and ownership report for Kirk Look. Currently GuruFocus does not have mailing address information for Kirk Look.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
